Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the reliability and validity of a new device with standard methods for diagnosing between amniotic fluid leakage due to premature rupture of the membranes (PROM) and urine.


Clinical Trial Description

Pregnant women sensing wetness and arriving to the delivery room with suspect PROM will use a self-testing device to test whether the wetness is caused by amniotic fluid leakage or urinary incontinence. Clinical evaluation will be performed to all pregnant women using standard clinical tests. The results of the standard clinical tests will be compared to the women's reading of the self-testing device results. Sensitivity and specificity of the device evaluation will be calculated. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01517633
Study type Interventional
Source Hadassah Medical Organization
Contact
Status Active, not recruiting
Phase Phase 2/Phase 3
Start date January 2012

See also
  Status Clinical Trial Phase
Recruiting NCT04963465 - The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
Completed NCT04100252 - The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes
Completed NCT03190434 - Pivotal Study of the AL-SENSE in Diagnosis Amniotic Fluid Leakage N/A
Completed NCT00604838 - Pivotal Study of the Al-Sense Study Protocol Phase 1/Phase 2